Discover
NYXH
Nyxoah SA
1.78
1 x 1.39
5 x 1.61
bid
ask
+
0.09
5.33%
3 @ 04:00 PM
1.76 -0.02 (1.12%)
| Ytd | -61.30% | |
| 1y | -76.88% |
1.67
day range
1.80
1.26
52 week range
8.59
| Open | 1.72 | Prev Close | 1.69 | Low | 1.67 | High | 1.80 | Mkt Cap | 177.87M |
| Vol | 156.27K | Avg Vol | 260.51K | EPS | -2.43 | P/E | N/A | Forward P/E | -5.03 |
| Beta | 0.55 | Short Ratio | 2.45 | Inst. Own | 35.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 2.47 | 200-d Avg | 4.04 | 1yr Est | 15.60 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-06 | 2024-09 | -0.46 | -0.55 | -0.09 | -19.57% |
| 2024-08-06 | 2024-06 | -0.45 | N/A | N/A | N/A |
| 2024-08-06 | 2024-06 | -0.45 | -0.46 | -0.01 | -2.22% |
| 2024-05-14 | 2024-03 | -0.45 | -0.45 | N/A | N/A |
| 2024-05-14 | 2024-03 | -0.45 | N/A | N/A | N/A |
| 2024-03-05 | 2023-12 | -0.41 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-12-13 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-11-05 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
| 2024-10-11 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-09-30 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-08-07 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
| 2024-08-07 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Profile
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | FMR, LLC | 1.72M | 13.72M | 4.99% |
| 2024-09-29 | Blackrock Inc. | 1.19M | 9.49M | 3.45% |
| 2024-09-29 | Franklin Resources, Inc. | 292.57K | 2.34M | 0.85% |
| 2024-09-29 | Millennium Management Llc | 187.37K | 1.50M | 0.55% |
| 2024-06-29 | CVI Holdings, LLC | 183.59K | 1.47M | 0.53% |
| 2024-09-29 | AXA S.A. | 152.00K | 1.22M | 0.44% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-08-30 | Fidelity Small Cap Growth Fund | 667.56K | 5.34M | 1.94% |
| 2024-09-29 | BlackRock Health Sciences Term Trust | 648.04K | 5.18M | 1.89% |
| 2024-10-30 | Fidelity Select Portfolios - Pharmaceuticals | 479.07K | 3.83M | 1.39% |
| 2024-08-30 | Blackrock Funds-Health Sciences Opportunity Portfolio | 411.25K | 3.29M | 1.20% |
| 2024-09-29 | Fidelity Central Investment Port-International Equity Central Fd | 335.70K | 2.69M | 0.98% |
| 2024-07-30 | Putnam Fds Tr-Putnam Multi Cap Core Fd | 282.46K | 2.26M | 0.82% |